Discover the latest breakthroughs in lymphocyte engineering.
The Conference will explore how the latest advances are being translated into real-world medical applications. As the only international conference dedicated specifically to the research and clinical translation of gene therapy, cell therapy, genome engineering, and immunotherapy, ICLE provides a unique platform for scientific exchange and collaboration.
Across diverse sessions, experts will present cutting-edge developments including in vivo lymphocyte engineering, next-generation CAR and TCR technologies, non-viral gene targeting, and novel immune cell platforms beyond conventional T cells. The program will also examine emerging therapeutic strategies for cancer, autoimmune diseases, and other conditions, while addressing key challenges in clinical translation and combination therapies.
Join us on 15-17 July 2026, in Milan, Italy for ICLE 2026.
Please note that the program is subject to changes.
Join us at the leading international event dedicated to lymphocyte engineering and immune-gene therapy.
The world’s foremost experts in gene therapy, cell therapy, genome engineering, and immunotherapy will gather to share the latest breakthroughs and clinical advances shaping the future of treatment for cancer, autoimmune diseases, infectious diseases, and immune deficiencies.
28
Speakers
10
Sessions
21
Presentations
XX
Posters
X
Industry presentations
Be part of this leading international event
Whether you are an established expert looking to stay at the forefront of lymphocyte engineering, or an emerging researcher or clinician eager to connect with leaders in the field, ICLE 2026 promises a dynamic, interactive, and inspiring experience for all.
